Asset Purchase Agreement by and between Gilead Sciences, Inc. and Sarepta Therapeutics Inc.Asset Purchase Agreement • May 4th, 2017 • Sarepta Therapeutics, Inc. • Pharmaceutical preparations • New York
This Asset Purchase Agreement (this “Agreement”) is made and entered into as of February 20, 2017 (the “Effective Date”), by and between GILEAD SCIENCES, INC., a corporation organized under the laws of the Delaware (“Buyer”), and SAREPTA THERAPEUTICS INC., a corporation organized under the laws of Delaware (“Seller”). Buyer and Seller may hereinafter be referred to individually as a “Party” and collectively as the “Parties”.
